Advertisement
Alimentary Tract| Volume 53, ISSUE 3, P324-328, March 2021

Download started.

Ok

Systemic steroids have a role in treating esophageal strictures in pediatric eosinophilic esophagitis

Published:December 15, 2020DOI:https://doi.org/10.1016/j.dld.2020.11.025

      Abstract

      Background

      The role of systemic steroids in the treatment of esophageal strictures in children with Eosinophilic Esophagitis (EoE) is poorly defined.

      Aims

      To describe a cohort of children with EoE-associated esophageal strictures responding to systemic steroids.

      Methods

      Retrospective review of medical records of children with EoE and moderate (<9 mm) to severe (<6 mm) strictures, who responded clinically and endoscopically to systemic steroids.

      Results

      Twenty children (median age 10.6 ± 4.2 years; 17 males) from nine centers in six countries were included in the analysis; 16 had moderate and four, severe strictures; 18 had dysphagia or bolus impaction; median diagnostic delay was 8 months (IQR 3.5–35). Eighteen patients received oral systemic steroids (mean dose 1.4 mg/kg/day) for a median of 4 weeks, while two initially received IV steroids. All patients showed clinical improvement and 15/20 became asymptomatic. Stricture resolution at endoscopy was found in 19/20, while histological resolution of EoE (<15 eos/hpf) in 13/20. Only minor side effects were reported: hyperphagia (10/20); weight gain (5/20); hyperactivity (2/20) and acne (1/20). Esophageal dilation was required in 3/20 patients during a median follow-up of 48.5 months (IQR 26.7–73.2).

      Conclusion

      Children with EoE and esophageal strictures, may benefit from the use of a short course of systemic steroids, avoiding mechanical dilation.

      Keywords

      Abbreviations:

      EoE (Eosinophilic Esophagitis), GERD (Gastroesophageal Reflux Disease), PPI (Proton Pump Inhibitor)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Digestive and Liver Disease
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Schoepfer A.M.
        • Safroneeva E.
        • Bussmann C.
        • Kuchen T.
        • Portmann S.
        • Simon H.U.
        • et al.
        Delay in diagnosis of eosinophilic esophagitis increases risk for stricture formation in a time-dependent manner.
        Gastroenterology. 2013; 145 (e1-2Epub 2013 Aug 13PMID:23954315): 1230-1236https://doi.org/10.1053/j.gastro.2013.08.015
        • Dellon E.S.
        • Hirano I.
        Epidemiology and natural history of eosinophilic esophagitis.
        Gastroenterology. 2018; 154 (e3): 319‐332https://doi.org/10.1053/j.gastro.2017.06.067
        • Lucendo A.J.
        • Molina-Infante J.
        • Arias Á.
        • von Arnim U.
        • Bredenoord A.J.
        • Bussmann C.
        • et al.
        Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults.
        Unit. Eur. Gastroenterol. J. 2017; 5 (Epub 2017 Jan 23PMID:28507746PMCID: PMC5415218): 335-358https://doi.org/10.1177/2050640616689525
        • Hirano I.
        • Chan E.S.
        • Rank M.A.
        • Sharaf R.N.
        • Stollman N.H.
        • Stukus D.R.
        • et al.
        AGA Institute Clinical Guidelines Committee; joint task force on allergy-immunology practice parameters. AGA institute and the joint task force on allergy-immunology practice parameters clinical guidelines for the management of eosinophilic esophagitis.
        Gastroenterology. 2020; 158 (PMID:32359562): 1776-1786https://doi.org/10.1053/j.gastro.2020.02.038
        • Schaefer E.T.
        • Fitzgerald J.F.
        • Molleston J.P.
        • Croffie J.M.
        • Pfefferkorn M.D.
        • Corkins M.R.
        • et al.
        Comparison of oral prednisone and topical fluticasone in the treatment of eosinophilic esophagitis: a randomized trial in children.
        Clin. Gastroenterol. Hepatol. 2008; 6 (PMID:18237866): 165-173https://doi.org/10.1016/j.cgh.2007.11.008
        • Moawad F.J.
        • Molina-Infante J.
        • Lucendo A.J.
        • Cantrell S.E.
        • Tmanova L.
        • Douglas K.M.
        Systematic review with meta-analysis: endoscopic dilation is highly effective and safe in children and adults with eosinophilic oesophagitis.
        Aliment Pharmacol. Ther. 2017; 46: 96-105https://doi.org/10.1111/apt.14123
        • Runge T.M.
        • Eluri S.
        • Cotton C.C.
        • Burk C.M.
        • Woosley J.T.
        • Shaheen N.J.
        • et al.
        Outcomes of esophageal dilation in eosinophilic esophagitis: safety, efficacy, and persistence of the fibrostenotic phenotype.
        Am. J. Gastroenterol. 2016; 111 (Epub 2016 Jan 12PMID:26753894PMCID: PMC4758887): 206-213https://doi.org/10.1038/ajg.2015.399
        • Hoofien A.
        • Dias J.A.
        • Malamisura M.
        • Rea F.
        • Chong S.
        • Oudshoorn J.
        • et al.
        Pediatric Eosinophilic Esophagitis: Results of the European Retrospective Pediatric Eosinophilic Esophagitis Registry (RetroPEER).
        J. Pediatr. Gastroenterol. Nutr. 2019; 68 (PMID:30540712): 552-558https://doi.org/10.1097/MPG.0000000000002215
        • Schoepfer A.M.
        • Gonsalves N.
        • Bussmann C.
        • Conus S.
        • Simon H.U.
        • Straumann A.
        • et al.
        Esophageal dilation in eosinophilic esophagitis: effectiveness, safety, and impact on the underlying inflammation.
        Am. J. Gastroenterol. 2010; 105 (Epub 2009 Nov 24PMID:19935783): 1062-1070https://doi.org/10.1038/ajg.2009.657
        • Menard-Katcher C.
        • Furuta G.T.
        • Kramer R.E.
        Dilation of pediatric eosinophilic esophagitis: adverse events and short-term outcomes.
        J. Pediatr. Gastroenterol. Nutr. 2017; 64: 701-706https://doi.org/10.1097/MPG.0000000000001336
        • Liacouras C.A.
        • Wenner W.J.
        • Brown K.
        • Ruchelli E.
        Primary eosinophilic esophagitis in children: successful treatment with oral corticosteroids.
        J. Pediatr. Gastroenterol. Nutr. 1998; 26: 380-385https://doi.org/10.1097/00005176-199804000-00004
        • Liacouras C.A.
        • Spergel J.M.
        • Ruchelli E.
        • et al.
        Eosinophilic esophagitis: a 10-year experience in 381 children.
        Clin. Gastroenterol. Hepatol. 2005; 3: 1198-1206https://doi.org/10.1016/s1542-3565(05)00885-2
        • Dellon E.S.
        • Kim H.P.
        • Sperry S.L.
        • Rybnicek D.A.
        • Woosley J.T.
        • Shaheen N.J.
        A phenotypic analysis shows that eosinophilic esophagitis is a progressive fibrostenotic disease.
        Gastrointest. Endosc. 2014; 79 (e4): 577-585https://doi.org/10.1016/j.gie.2013.10.027
        • Shoda T.
        • Wen T.
        • Aceves S.S.
        • Abonia J.P.
        • Atkins D.
        • Bonis P.A.
        • et al.
        Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR). Eosinophilic oesophagitis endotype classification by molecular, clinical, and histopathological analyses: a cross-sectional study.
        Lancet Gastroenterol. Hepatol. 2018; 3 (Epub 2018 May 3PMID:29730081PMCID: PMC5997568): 477-488https://doi.org/10.1016/S2468-1253(18)30096-7